Skip to main content
Clinical Trials/NL-OMON31777
NL-OMON31777CompletedNot Applicable

Clinical Trial to Evaluate the Treatment of Atrial Fibrillation Using the Ablation Frontiers Cardiac Ablation System - The Atrial Fibrillation Ablation Pilot Study

Ablation Frontiers, Inc.0 sites20 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • History of symptomatic permanent atrial fibrillation lasting greater than seven days but less than four years with at least one failed DC cardioversion within the previous two years.

Exclusion Criteria

  • Structural heart disease of clinical significance.

Investigators

Sponsor
Ablation Frontiers, Inc.

Similar Trials